Rooshna Fatima

I am a clinical research coordinator with over 2 years of experience in leading Phase II-IV trials primarily in the areas of rheumatology and respiratory. I started with the OPTIONS Lab in October 2020. Currently, I am working on the CORIPREV and CATCO trials that investigate the role of antiviral treatments as COVID-19 PEP and antiviral treatments for hospitalized patients with COVID-19 respectively.

I am thrilled to be a part of both these projects and grateful for the opportunity to contribute to the fight against the COVID-19 pandemic.